Eur Rev Med Pharmacol Sci 2015; 19 (16): 3001-3005

Valve replacement for valvular heart disease with giant left ventricle

D. Han, Y. Zhang, D.-M. Xue, W.-L. Wang, W.-J. Yan

Department of Cardiothoracic Surgery, The First People’s Hospital of Xuzhou, Xuzhou, Jiangsu, China. zhangyanglaoshi@hotmail.com


OBJECTIVE: To discuss early efficacy of the cardiac patient with giant left ventricle underwent valve replacement.

PATIENTS AND METHODS: Fifty-five patients, who are suffering cardiac valve disease with giant left ventricle, underwent valve replacement. Among them, sixteen patients underwent aortic valve replacement; thirty patients underwent mitral valve replacement; nine patients underwent double valve replacement. All of them use mechanical heart valve.

RESULTS: The number of early death after operation was five. Two patients died of malignant arrhythmia; two died of intractable low cardiac output syndrome; the last one’s mechanical valve lost its ability to function after operation and died of respiration-circulation failure after an emergency operation. The death rate was 9%. The remaining 55 patients were cured and their cardiac function was significantly improved.

CONCLUSIONS: The definite effective myocardial protection and perfect and detailed preoperative treatment can reduce the possibility of operative complications and death rate of this kind of patients.

Free PDF Download

To cite this article

D. Han, Y. Zhang, D.-M. Xue, W.-L. Wang, W.-J. Yan
Valve replacement for valvular heart disease with giant left ventricle

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 16
Pages: 3001-3005